Amgen Inc Stock Investor Sentiment

AMGN Stock  USD 317.17  3.46  1.10%   
About 53% of Amgen's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Amgen Inc suggests that some traders are interested. Amgen's investing sentiment overview a quick insight into current market opportunities from investing in Amgen Inc. Many technical investors use Amgen Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Comfort Level 53

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Amgen's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Amgen Inc.

Amgen Historical Sentiment

Although Amgen's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Amgen, such as negative comments on social media and news outlets, may cause fear in the market and push Amgen's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Amgen.
  

Amgen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Amgen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Amgen Inc Historical Investor Sentiment

Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amgen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amgen and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Amgen news discussions. The higher the estimate score, the more favorable the investor's outlook on Amgen.

Amgen Maximum Pain Price Across June 20th 2025 Option Contracts

Amgen's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Amgen close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Amgen's options.
over two weeks ago at thelincolnianonline.com         
Duncker Streett Co. Inc. Sells 62 Shares of Amgen Inc.
news
over two weeks ago at thefly.com         
Amgen, AstraZeneca announce results from Phase 3 WAYPOINT trial on tezspire AMGNAZN
news
over two weeks ago at thelincolnianonline.com         
Connable Office Inc. Sells 1,288 Shares of Amgen Inc.
news
over two weeks ago at gurufocus.com         
Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained ...
Gurufocus Stories at Macroaxis
over two weeks ago at gurufocus.com         
Amgen Inc Announces Positive Phase 3 Trial Results for TEZSPIRE in Treating Nasal Polyps
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Amgen Inc. Position Lessened by Peloton Wealth Strategists
news
over two weeks ago at finance.yahoo.com         
Why Amgen Inc. is the Best Vaccine Stock to Buy According to Hedge Funds?
Yahoo News
over two weeks ago at insidermonkey.com         
Why Amgen Inc. is the Best Vaccine Stock to Buy According to Hedge Funds?
insidermonkey News
over two weeks ago at insidermonkey.com         
Amgen Inc. Invests 200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025
insidermonkey News
over two weeks ago at finance.yahoo.com         
AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
Yahoo News
over two weeks ago at gurufocus.com         
Amgen Inc to Present at 45th Annual TD Cowen Health Care Conference
Gurufocus Stories at Macroaxis
over two weeks ago at businesswire.com         
BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
businesswire News
over two weeks ago at finance.yahoo.com         
Kidney Month 2025 Bringing Kidney Disease into the Spotlight
Yahoo News
over two weeks ago at businesswire.com         
Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highligh...
businesswire News
over two weeks ago at gurufocus.com         
Amgen Inc Gains FDA Approval for LUMAKRAS Combination Th
Gurufocus Stories at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amgen that are available to investors today. That information is available publicly through Amgen media outlets and privately through word of mouth or via Amgen internal channels. However, regardless of the origin, that massive amount of Amgen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amgen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amgen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amgen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amgen alpha.

Amgen Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Research Analysts Set Expectations for Amgen Q1 Earnings
02/27/2025
2
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
03/03/2025
 
Amgen dividend paid on 7th of March 2025
03/07/2025
4
Dow Jones Industrial Average resumes decline as sentiment withers
03/10/2025
5
Registration Open for 14th Annual Prevent Blindness Focus on Eye Health Summit, With Theme of Perspectives in Vison
03/11/2025
6
Amgens Options A Look at What the Big Money is Thinking
03/12/2025
7
Is Amgen Inc. the Best Pharma Stock to Buy According to Hedge Funds
03/13/2025
8
Regeneron falls after appeals court ruling in Eylea case
03/14/2025
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.19)
Dividend Share
9
Earnings Share
7.56
Revenue Per Share
62.242
Quarterly Revenue Growth
0.109
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.